IMUX - Immunic, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.85 0.0 (0.32%)	0.0 (0.0%)	0.0 (0.0%)	-0.01 (-0.7%)	0.02 (2.2%)	-0.01 (-1.65%)	0.02 (2.02%)	0.02 (2.02%)

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.2
Diluted EPS:: -0.2
Basic P/E:: -4.2695
Diluted P/E:: -4.2695
RSI(14) 1m:: 79.17
VWAP:: 0.85
RVol:: 0.752

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.85 +0.01 (+1.44%)	Oct 15 18:07
1m	Price increase 1m	0.85 +0.01 (+1.55%)	Oct 15 16:42
1m	Price decrease 1m	0.83 -0.01 (-1.17%)	Oct 15 13:38
1m	Price decrease 1m	0.84 -0.01 (-1.29%)	Oct 15 13:06
1m	Price decrease 1m	0.85 -0.01 (-1.02%)	Oct 15 09:40